OPEN LETTER TO THE EUROPEAN PARLIAMENT ON THE CASE OF
A SERIES OF LETHAL OUTBREAKS OF LISTERIA IN THE EU
THAT CAN BE PREVENTED
IF DG SANTE FOLLOWS A CALL TO ESTABLISH A NEW PHAGE REGULATION
The Hague, November 18th, 2019
Dear Member of the European Parliament,
Over the past 2 months outbreaks of the deadly bacterium Listeria on food occurred in
Spain, Germany and The Netherlands. The resulting disease listeriosis killed and
seriously debilitated around 1,000 persons, including several miscarriages. Despite the
strict EU Regulations on hygiene, Listeria contamination of especially Ready-To-Eat
(RTE) food is very difficult to combat, due to the resilience of the bacterium and the fact
that it is naturally present in our environment. There is, however, a product that can
reduce the number of listeriosis victims considerably: the phage-containing product
ListexTM P100, produced by the company Micreos. According to independent experts,
Listex, when used on RTE food, is able to prevent up to 74% of listeriosis cases. This
safe and natural phage specifically kills only Listeria bacteria and has no effect on other
types of bacteria. Consequently, its cannot be used to cover up a lack of hygiene by
food processors. Nevertheless, the European Commission’s DG SANTE (responsible
for public health) has in the past 12 years not been able to appropriately regulate
Listex.
This is despite the fact that the European Food Safety Authority has established in
2016 that Listex P100 is absolutely safe and effective. This is despite the fact that since
2006 Listex has been approved and safely used as a processing aid in major markets
around the world, including the USA, Canada, Australia and Switzerland. Despite
protests from the European Parliament, DG SANTE has cast a cloud of uncertainty
over a life-saving product.
Since 2006, Micreos has endeavoured to get confirmation of the use of Listex as a
‘non-decontaminating processing aid’ on animal-derived RTE food. Against expert
advice, DG SANTE determined that this product should be regarded as a
‘decontaminant’ and therefore needed an authorisation under EU Regulation 853/2004.
Even though top phage experts explained that Listex can be used only to prevent the
outgrowth of Listeria on RTE food and not to decontaminate it, DG SANTE forced
Micreos to start an authorisation of Listex as a ‘decontaminant’. Why was this wrong?
Because Listex is used during production of RTE food that contains far less Listeria
than the legally allowed number of 100 Colony Forming Units per gram final RTE food.
This food is not ‘contaminated’ and thus cannot be de-contaminated either. This may
have been among the reasons why EU Member States questioned DG SANTE’s
choice of authorisation procedure. Because DG SANTE ‘was too busy’ with other
dossiers, the civil servants subsequently decided to simply stop the procedure and then
started to actively and inappropriately imply that use of Listex was illegal, exposing
1
European citizens to new and deadly listeria outbreaks - which indeed materialised
since, despite DG SANTE’s claims this would not happen.
As advised by a new Director General, Micreos challenged DG SANTE’s policies and
actions before the European Union Court of Justice (EUCJ). DG SANTEs written
‘’advice” of 17th June 2019 – before the new outbreaks – explicitly included that DG
SANTE did not take a decision on the legal classification of the use of Listex on RTE
food of animal origin, but merely interpreted Regulation 853/2004. It seems DG SANTE
took this position to avoid that the EUCJ would apply Interim Measures potentially
leading to serious compensation claims by (relatives of) Listeria victims as well as
Micreos to the European Commission. Indeed, the Court Order does not apply Interim
Measures, but it argues that DG SANTE did not take any decision regarding Listex as it
only aborted its own decontamination authorization procedure under regulation
853/2004. Furthermore, the Court Order refers to the ‘non-decontaminating’ function of
Listex, while establishing that the absence of a Commission decision restores the
position of the use of Listex as a non-decontaminating processing aid before DG
SANTE started its failing decontamination authorization route. The Court proceedings
are ongoing and a decision by the EUCJ is expected in one year and half – a very long
time during which many more European citizens will fall victim to Listeria outbreaks.
Nevertheless, and apparently at the invite of one Member State, DG SANTE tried to
once again block the marketing of Listex – without DG SANTE haven taken any
decision! How can a mere interpretation of the DG SANTE be enforced?
In its letter of 8th November 2019 DG SANTE does not react to lethal outbreaks. It
shows no empathy with the victims and their families. Instead, in this non-public letter
to the Chief Veterinarians in all EU Member States, DG SANTE enquires whether
Listex is used and implies that such use would be illegal (please see the DG SANTE
letter attached; a legal rebuttal of this letter is attached as well). In this letter, the
European Commission suggests that water should be used to prevent bacterial
contamination. This is scientific nonsense, as water actually supports bacterial growth.
Moreover, washing RTE products like cheese and sausages with water is equally
nonsensical. Last but not least, DG SANTE explicitly states that it was Micreos which
requested the use of Listex on animal-derived RTE food to be regulated as a
decontaminating processing aid. Again, this misleads the readers: DG SANTE forced
Micreos to take this incorrect regulatory route.
To the total astonishment of Micreos and most if not all scientific and regulatory
experts, after 12 years, the European Commission not only neglected its role as
regulator but has started to harass and discredit Micreos and Listex. The persistence of
DG SANTE to not immediately address the case of Listex totally ignores the present
risks of loss of (unborn) life and lifelong serious health problems and seems to protect
rather its own position than public health and the European Union’s top priorities
including innovation and the support to Small and Medium Sized Enterprises, such as
Micreos and the high priority to develop alternatives to antibiotics in the face of the
health threat of antibiotic resistance. Indeed, on 15 November 2019 the European
Court of Auditors’ report on Antimicrobial Resistance mentions that in the EU One
Health Action Plan on AMR, the Commission set the objective to support SMEs in
their research and development efforts. The role of SME’s in the discovery of
2
antimicrobials is increasing, particularly given the withdrawal of large pharmaceutical
companies from such research. However, only a mere 5% of funding from the DG
SANTE’s ND4BB programme of 357million Euro had been used for SMEs. There
seems to be a pattern. And it is not shared by other DGs of the European
Commission: In 2019 DG RTD (Research) awarded to Micreos the highest possible
grant under its Horizon 2020 program to accelerate the availability of Micreos’ targeted
antibacterial products, set to replace antibiotics. According to the jury representing the
European Commission this technology has a high chance of success to improve the
social wellbeing and global competitiveness of the EU and its citizens. Obviously, the
positions and acts of DG SANTE towards Listex are a far cry from all of this.
In the recent past, key Members of the European Parliament have already called
on DG SANTE to develop the earliest possible framework for a new phage
regulation while considering the use of Listex as a non-decontaminating
processing aid in the meantime. As in other cases involving SMEs, DG SANTE
turned down this best way out.
Threatened in our existence, after heavily investing in effectively combating listeriosis
in a spirit of private and public interest altogether, we must now call on the European
Parliament to immediately take steps towards the creation of a new phage
regulation while considering the use of Listex as a safe and effective non-
decontaminating processing aid on RTE animal-derived food. As a Member of the
European Parliament, the only EU institution with democratic legitimation, you can help
save human lives unnecessarily jeopardised by DG SANTE’s 12 year-long bureaucratic
approach. Please have the Commission publicly explain why it prefers to protect its
previous erroneous decisions above protecting public health and food safety. As many
other innovative SMEs, Micreos cannot survive without your support and neither can
those exposed to an ever-growing listeria threat.
I am entirely at your disposal for consultation and information and thank you in advance
for your highly appreciated attention and support.
Yours sincerely,
Mark Offerhaus
CEO
Attachments:
- Letter of DG SANTE to Chief Veterinarian Officers, 8 November 2019
- Mail of Micreos in response to DG SANTE letter (English translation), 18
November 2019
3
Ref. Ares(2019)6915736 - 08/11/2019
EUROPEAN COMMISSION
DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY
Crisis management in food, animals and plants
The Director
Brussels,
S ANTE.DDG2.G4/ACG(2019)5740164
Subject: Absence of authorisation at EU level of Listex P100 for use in food of
animal origin.
Dear colleagues,
At the meeting of the food hygiene working group on 29 April 2019, request was made
to the Commission to clarify the status of the product Listex™ PI00 as decontaminant in
ready-to-eat foods of animal origin contaminated with Listeria. The Member States
raised the fact that this product was advertised to business operators producing food of
animal origin despite not being allowed on the market.
Regulation (EC) No 853/2004 laying down specific hygiene rules for food of animal
origin 1 forbids the use of any substance other than potable water for the decontamination
of food of animal origin, unless expressly allowed.
Article 3(2) of that Regulation stipulates: "Food business operators shall not use any
substance other than potable water— or, when Regulation (EC) No 852/2004 or this
Regulation permits its use, clean water — to remove surface contamination from
products of animal origin, unless use of the substance has been approved by the
Commission”.
The authorisation of substances for decontamination is thus done by derogation from the
hygiene rule established in Regulation (EC) No 853/2004 .
In 2015 Micreos Food Safety submitted a request for approval of Listex™ PI00, a
phage-based product, for use against the contamination with Listeria of ready-to-eat
food, on the basis of Article 3(2) of Regulation (EC) No 853/2004. The request was
processed by the Commission, and in 2016 the EFSA delivered an opinion "Evaluation of
the safety and efficacy of ListexTMPlOO for reduction of pathogens on different ready-
to-eat (RTE) food products." In 2017 discussions on this issue took place both in the
working group and in the Standing Committee on Plants, Animals, Food and Feed.
From the discussions, it became clear that there was an opposition against the required
approval of Listex™ PI00. In that regard, by letter dated 19 February 2018, the
Commission informed Micreos Food Safety of its decision that it did not intend to pursue
the evaluation of the application.
1 Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 2004 laying
down specific hygiene rules for food of animal origin (OJ L139 30.4.2004 p. 55)
Chief Veterinary Officers of the Member States
Commission européerme/Europese Commissie, 1049 Bruxelles/Bmssel, BELGIQUE/BELGIË - Tel. +32 22991111
Office: B232 03/003 - Tel. direct line +32 229 93338
With regard to the claim that the product should be considered as a processing aid, falling
outside Regulation (EC) No 853/2004, it should be noted that processing aids are defined
in Regulation (EC) No 1333/2008 on food additives2. However, Listex™ PI00 aims at
reducing the Listeria contamination in ready-to-eat food of animal origin. It therefore
falls under the scope of Article 3(2) of Regulation (EC) No 853/2004. Therefore, a
possible qualification as a processing aid for the purpose of decontamination would not
remove the prevailing authorisation obligation under Regulation (EC) No 853/2004.
In August 2019, Micreos made an application to the EU General Court for annulment of
the letters of the Director General for SANTE of 17 June 2019, by which, according to
the applicant, the Commission would have stopped the authorisation procedure for
Listex™ PI 00 and prohibited the placing on the market of Listex™ PI00 as a processing
aid. Micreos also made an application for interim measures, which was dismissed as
inadmissible by the President of the General Court by Order of 26 September 2019.
Nevertheless, this does not mean, as apparently claimed by Micreos that the (President of
the) General Court has considered that Listex can be marketed. Paragraph 48 of the
Order states that [...Jaccording to the Commission's view, as expressed in the two letters,
Listex™ PI 00 falls within the scope of Article 3(2) of Regulation No 853/2004. This
implies prima facie that, by virtue of that provision, the qualification as a processing aid
for the purpose of decontamination cannot remove the prevailing authorisation
obligation under Regulation No 853/2004.
Moreover, the President of the General Court clarified in paragraph 49 of his Order that
the alleged prohibition on the marketing of Listex™ PI 00 in ready-to-eat foods of animal
origin “stems prima facie, directly, from Regulation No 853/2004, as interpreted by the
Commission”.
Therefore, although the General Court has not issued a judgement on the main
application yet, it has not followed at all the applicant’s arguments for interim measures.
As already recalled at the meeting on 29 April 2019, there is no authorisation granted for
the placing on the market of Listex™ PI 00 in accordance with Article 3(2) of Regulation
(EC) No 853/2004 for its use in food of animal origin and there is, in the view of the
Commission, no scope for Member States to authorise Listex as processing aid for food
of animal origin.
I would ask you to send DG SANTE information on the use
country and on which product it is used.
Yours sincerely,* (i)
2 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008
on food additives , OJ L 354 31.12.2008, p. 16 . Its Article 3(2)(b) states:
"‘processing aid’ shall mean any substance which:
(i) is not consumed as a food by itself;
(ii) is intentionally used in the processing of raw materials, foods or their ingredients, to fulfil a
certain technological purpose during treatment or processing; and
(iii) may result in the unintentional but technically unavoidable presence in the final product of
residues of the substance or its derivatives provided they do not present any health risk and do not
have any technological effect on the final product"
2
Electronically signed on 07/11/2019 16:57 (UTC+01) in accordance with article 4.2 (Validity of electronic documents) of Commission Decision 2004/563
Translation of email of Mr Dirk de Meester, Micreos, to a senior officer of the Ministry of Health,
Wellbeing and Sport of The Netherlands, 18 November 2019, in response to a letter of DG SANTE
regarding listeria outbreaks/Listex P100 of 8 November 2019: the European Commission has taken
no decision, therefore there is nothing to be enforced
Many thanks for your mail with appendix dated 13 November 2019. Micreos is also grateful for your
statements during the Working Group on Additives meeting in Brussels on Friday 8 November 2019,
in which you criticised DG SANTE for the fact that since 2006 the European Commission has not
succeeded in setting up an adequate regulatory framework for the use of phages in general and for
Listex P100 in particular. Increasing concern has been expressed both in the European Parliament
and elsewhere about this delay and about ignoring increasing numbers of victims of listeria
outbreaks in many Member States of the European Union. This will lead to far-reaching action. It
goes without saying that a commitment by the European Commission in response to a call from the
European Parliament to come up with a new regulation on phages and to regard the use of Listex
P100 as a ‘non-decontaminating’ processing aid in ready-to-eat foods of animal origin in the
meantime, is a (face saving) rescue solution for all parties involved and, above all, for the Listeria
victims.
The interpretation of your Department's lawyers is in fact an interpretation of the European
Commission's interpretation with regard to the application of Article 3(2) of Regulation 853/2004.
The EU Court of Justice has explicitly quoted this interpretation of the European Commission,
indicating that Micreos has the right to challenge Member States' positions on Listex P100 before a
national court if they prevent the marketing of Listex P100 for use as a non-decontaminating process
aid. From a legal perspective, it can be added that DG SANTE’s 'interpretation' cannot lead to legal
consequences. The fact that this is an interpretation is also evident from the letter from Director-
General Anne Bucher dated 17 June 2019 (attachment 1). For a better understanding, the report of
the meeting with Mrs Bucher dated 28 June 2019 (attachment 2) is also added. This meeting was
attended by the Belgian former Prime Minister Mark Eyskens and a lawyer. A procedure before a
national court should lead to a referral to the EU Court for a preliminary ruling that definitively
interprets the applicable law in a way that is binding for all. As you know, the Commission has
(deliberately or not) only included Article 3(2) of Regulation 853/2004 in its interpretation, whereas
Article 2.1(f) of Regulation 852/2004 (i.e. the definition of contamination) in combination with
Annex I, Chapter 1 of Regulation 2073/2005 (i.e. the amount of permitted Listeria bacteria in ready-
to-eat foods) are also applicable.
Our lawyer Spyros Pappas has spoken to Mr. Thévenard of the European Commission. He kindly
referred to you to provide us with a copy of the Commission letter of 8 November 2019. As he
referred to the acquisition of this letter via the Dutch government, I would ask you to inform the
European Commission of our reaction to this letter via the same line, with a copy to all other
members of the Working Group. It should be noted that Micreos does not follow the European
Commission's interpretation of the Court Order of the EU Court. The arguments put forward by
Spyros Pappas for this purpose are set out below:
1. Pursuant to consideration 9 of the Order of 26 September 2019 of the President of the
General Court “by letter of 9 May 2019, the applicant requested the Commission to
acknowledge the use of Listex™ P100 on animal-derived Ready-To-Eat (RTE)-Food as a non-
decontaminating processing aid”.
2. According to consideration 25 of the same Order, Micreos sought “the suspension of
operation of an alleged decision by the Commission of 17 June 2019 by which it purportedly
prohibited the placing on the EU market of the applicant’s product Listex™ P100 as a non-
contaminating processing aid for use on animal-derived RTE-Food”.
3. Consideration 27: “The Commission contends that the present application is inadmissible due
to the non-existence of the alleged decision, attacked in the main proceedings”.
4. Indeed, the Commission admits that it has not made a decision prohibiting Listex™ P100 as a
non-(de)contaminating processing aid.
5. On the other hand, consideration 45 confirms that “the Commission takes a position as to the
question whether the use of Listex™ P100 on animal-derived RTE falls under the scope of
Article 3(2) of Regulation No 853/2004 and whether the obligation of an EU authorisation
continues to apply for the marketing as a processing aid for the purpose of decontamination
of RTE-Food”.
6. To this extent the Order concludes that the position of the Commission is nothing more than
“a mere interpretation of the applicable legal framework” (cons. 50), that, if the interpretation
of the Commission is right, an authorisation would be required because the use of Listex™
P100 on animal-derived RTE food should be considered as a processing aid which is
decontaminating. However, this interpretation remains open until the final Judgment on the
Micreos application for annulment in which Micreos, among others, claims that the
Commission was wrong in its qualification as a ‘decontaminating processing aid’. Until that
moment, the situation ex ante is restored, namely that Listex P100 can keep on being traded
as a non-decontaminating processing aid on animal-derived RTE food. The Court Order
justifies that Micreos can take Member States to national Court and the latter refer the case
to the Court of Justice of the EU if such trading is prohibited. From a scientific point of view
this is also correct: Listex™ P100 is only effective and relevant to be applied if the number of
bacteria stays under the legally permitted volume. If that legal limit is exceeded the food
product is contaminated. If that is not exceeded there is NO contamination and ListexTM P100
is applied in a preventive manner. This is exactly why the Court will have referred to the word
‘non-decontaminating’ processing aid.
7. In view of the above, Micreos informed its stakeholders that, at present, following the Order
of the President there is no explicit prohibition of the marketing of the use of Listex™ P100 on
animal-derived RTE food. This is corroborated by the fact that the product is on the market
since many years now, not to speak about the USA, Canada and Australia where it is formally
recognised as a processing aid. Moreover, Micreos expressed its hope that thanks to the
pending proceedings the way for natural phages against Listeria is paved.
8. It is with regret that Micreos learned informally about a non-public letter of 8 November 2019
of the Commission to the Chief Veterinary Officers of the Member States; in this letter the
Commission turns the established absence of a decision prohibiting the marketing of Listex™
P100 leaving Micreos without judicial protection, into an explicit “Absence of authorisation at
EU level of Listex™ P100 for use in food of animal origin” with the view to concluding that, “in
the view of the Commission” (hence, another interpretation escaping judicial control), there is
“no scope for Member States to authorise Listex as processing aid for food of animal origin”.
In this way, without making a challengeable decision and acting beyond its remit, it stimulates
Member States to prohibit the marketing of Listex™ P100. In doing so, it omits to clearly
remind the positive Scientific Opinion of EFSA and interprets the need of Member States to
get guidance in this regard in order to cope with the renewed expansion of Listeria and
subsequential listeriosis as being an opposition, leaving thus the EU citizens unprotected.
9. Micreos, despite the damage it is suffering, is not going to further contest this unnecessary
comeback of the Commission on the issue since the proceedings before the General Court on
the application for annulment are imminent. It would like, however, to point out that
whatever the case might be, it is a pity for the Commission as Guardian of the common
interest to have stuck to its own interpretation of verbal formalities instead of effectively
creating a legal framework in which Listex™ P100 finally does what is needed to prevent that
EU citizens who are entitled to optimal protection continue to mourn further losses of human
(unborn) lives.
As you know Mr Pappas is the former Director General for Consumer Affairs of the European
Commission. He knows the processes and procedures within the European Commission which
sometimes loses contact with reality and social desirability.
In advance I thank you very much for noting our position. Of course, you will be aware of the fact
that the rather premature letter of the European Commission once again creates a serious
disadvantage for Micreos within the European market. This is contrary to the two priorities of the
European Union (support for innovation and SMEs and the requirement to develop alternatives for
antibiotics with the highest urgency to combat antibacterial resistance) and to the awarding to
Micreos of the highest grant under the HORIZON 2020 program by the same European Commission.
Yours Sincerely,
Dirk de Meester
Director Business Development
Micreos Food Safety
Saatja: Karen Meesen <
[email protected]>
Saadetud: 21.11.2019 18:25
Adressaat: SM Info <
[email protected]>
Teema: FW: Letter for H.E. the Minister of Health
Manused: 1. 2019-11-18 Open Letter Micreos to MEPs.pdf; 2. 2019-11-18 English translation
Micreos letter to Dutch Ministry of Health.pdf; 3. 2019-11-08 Letter of DG Sante Director
Bernard Van Goethem re absence of authorization Listex on food of animal origin.pdf;
Estonia.pdf
To the office of H.E. Riina Sikkut
Dear Madam, dear Sir,
On behalf of Prof. Mark Eyskens, former Prime Minister of Belgium, may I kindly request you to present
his letter, regarding the prevention of further listeria victims in Europe, to H.E. the Minister, together
with its attachments. We are very grateful for your assistance.
Yours sincerely,
Karen Meesen
PA International Foundation
Franklinstraat 106-108, 1000 Brussels, Belgium
Tel: (+32)(0)2 735 83 96, Fax: (+32)(0)2 735 84 66
Email:
[email protected]
www.pa-international.org
Disclaimer
1. This e-mail is for the intended recipient only. If you have received it by mistake please let us know by reply and then delete it from your
system; access, disclosure, copying, distribution or reliance on any of it by anyone else is prohibited.
2. If you as intended recipient have received this e-mail incorrectly, please notify the sender (via e-mail) immediately. This e-mail is confidential
and may be legally privileged. PA International does not guarantee that the information sent and/or received by or with this e-mail is correct
and does not accept any liability for damages related thereto.
H.E. Riina Sikkut
Minister of Health and Labour of Estonia
By email:
[email protected]
Brussels, 21 November 2019
Ref. nr.: 19.38900
Your Excellency,
It has been particularly moving to be informed about the loss of unborn life as a consequence
of listeria outbreaks in Spain, Germany and the Netherlands in the past two months. Around
1,000 European citizens died, were maimed or suffered other consequences of food poisoning
by the most lethal foodborne pathogen listeria bacteria. As a former Prime Minister, I
understand the burden of correctly applying laws and regulations while ultimately prioritizing
the protection of human lives.
In the case of recurrent, increasingly frequent and lethal outbreaks of listeria European society
has reached a point that technical debates no longer serve European citizens’ public health.
The best of scientists including the European Food Safety Authority have established that the
phage Listex P100 is totally safe and effective. This product is used legally and correctly in all
major global markets but in the EU the lack of a phage regulation has seduced DG SANTE to try
to regulate the use of Listex P100 on animal-derived Ready-To-Eat food in an evidently less
fitting regulatory environment. It should be understood also by DG SANTE that a specific phage
regulation has many benefits including that such regulation only applies to phages. Key
Members of the European Parliament of all major Groups therefore already called on the
European Commission to create a specific phage regulation and to consider the use of Listex
P100 a processing aid for use on animal-derived food. According to the European Commission
itself, phages may have a decisive role to play in combating Antimicrobial Resistance and
several other potentially lethal infections. Therefore, this month DG RTD awarded the highest
possible grant under the Horizon 2020 program to the Dutch SME Micreos for its innovative
and effective investment in the development and production of new life-saving phage-derived
products. Obviously, this reflects the European Union’s policy to strongly support both
innovation and SME development. I regret to say that DG SANTE apparently does not: please
refer to the attached letter of Micreos CEO Mr Mark Offerhaus to all Members of the
European Parliament. I wholeheartedly support this letter and also the attached letter by
Micreos to the Dutch authorities which kindly provided Micreos with a non-public letter in
which DG SANTE tries to convince the Chief Veterinary Officers of the EU Member States to
take action against Listex P100 even though DG SANTE maintains vis-à-vis the European Union
Court of Justice that it has taken no decision on the regulatory position of Listex P100. I
support the legal analysis of Micreos’ lawyer and former Director General for Consumer Affairs
of the European Commission Mr Spyros Pappas, that ‘interpretations’ of the European
Commission cannot lead to any form of enforcement in law – unless the European Commission
is both regulator and judge.
Thank you very much in advance for helping to ensure that the European institutions protect
our health and human lives, also in order to convince Generation Z that the European
Commission is there for them.
Yours sincerely,
Prof. Mark Eyskens
Chairman, PA International Foundation
Minister of State and former Prime Minister of Belgium
Attachments:
- Open Letter of Mark Offerhaus, CEO of Micreos, to all Members of the European
Parliament, 18 November 2019
- Mail of Dirk de Meester, Director Business Development of Micreos, to the Dutch
Ministry of Health, 18 November 2019 (English translation)
- Letter of DG SANTE to the Chief Veterinary Officers of the EU Member States, 8
November 2019